Latest filing published 21 Nov 2024 for 원바이오젠.
교보증권: trading record in brief
All filings by 교보증권 on record concern 원바이오젠. We count 11 filings; the first trade dates from 2 March 2021 and the latest from 1 November 2024.
Every open-market trade on record is a sale: 11 sales. No amount is published for 11 filings, which the totals therefore leave out. In 2024 alone, the filings show no purchases and 1 sale.
The latest filing, published on 21 November 2024, reports an open-market sale in 원바이오젠. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 교보증권
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,966,101 sharesKRXDART:20241121000346
- 2,966,101 sharesKRXDART:20230907000240
- 2,966,101 sharesKRXDART:20221012000402
- 2,966,101 sharesKRXDART:20221012000406
- 2,966,101 sharesKRXDART:20221012000400
- 2,966,101 sharesKRXDART:20221012000404
- 2,966,101 sharesKRXDART:20221012000405
- 2,966,101 sharesKRXDART:20211105000427
- 2,966,101 sharesKRXDART:20210409001937
- 2,966,101 sharesKRXDART:20210308000377
- 2,966,101 sharesKRXDART:20210302000239
11 of 11 declarations